{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:01:09Z","timestamp":1778796069340,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["5K12HD043483"],"award-info":[{"award-number":["5K12HD043483"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K23DA047476"],"award-info":[{"award-number":["K23DA047476"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG043471"],"award-info":[{"award-number":["R01AG043471"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01DA045729"],"award-info":[{"award-number":["R01DA045729"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA051683"],"award-info":[{"award-number":["K01DA051683"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics & Gynecology MFM"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ajogmf.2021.100475","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T12:10:39Z","timestamp":1629979839000},"page":"100475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The risk of serious opioid-related events associated with common opioid prescribing regimens in the postpartum period after cesarean delivery"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0699-4224","authenticated-orcid":false,"given":"Andrew D.","family":"Wiese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7626-9992","authenticated-orcid":false,"given":"Sarah S.","family":"Osmundson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Edward","family":"Mitchel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Adgent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4230-4454","authenticated-orcid":false,"given":"Sharon","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6958-0371","authenticated-orcid":false,"given":"Stephen W.","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-8311","authenticated-orcid":false,"given":"Andrew J.","family":"Spieker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos G.","family":"Grijalva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2021.100475_bib0001","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.surg.2017.04.016","article-title":"Variation in the cost of 5 common operations in the United States","volume":"162","author":"Wakeam","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0002","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.7863","article-title":"Rates of new persistent opioid use after vaginal or cesarean birth among US women","volume":"2","author":"Peahl","year":"2019","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0003","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/AOG.0000000000002095","article-title":"Postdischarge opioid use after cesarean delivery","volume":"130","author":"Osmundson","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0004","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/GCO.0000000000000527","article-title":"Opioid prescribing after childbirth: overprescribing and chronic use","volume":"31","author":"Osmundson","year":"2019","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0005","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7326\/M19-3805","article-title":"Opioid prescribing after childbirth and risk for serious opioid-related events: a cohort study","volume":"173","author":"Osmundson","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0006","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ajog.2018.10.026","article-title":"Delivery type, opioid prescribing, and the risk of persistent opioid use after delivery","volume":"220","author":"Osmundson","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2018.08.039","article-title":"Inpatient opioid use after vaginal delivery","volume":"219","author":"Badreldin","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0008","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ajog.2019.11.1248","article-title":"Association between neuraxial analgesia and postpartum opioid use following vaginal delivery","volume":"222","author":"Badreldin","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0009","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/ALN.0000000000001789","article-title":"Recovery after nulliparous birth: a detailed analysis of pain analgesia and recovery of function","volume":"127","author":"Komatsu","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.03.020","article-title":"New persistent opioid use after acute opioid prescribing in pregnancy: a nationwide analysis","volume":"223","author":"Peahl","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0011","article-title":"Variation in discharge opioid prescribing after vaginal births","volume":"3","author":"Min","year":"2021","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.04.030","article-title":"Better late than never: why obstetricians must implement enhanced recovery after cesarean","volume":"221","author":"Peahl","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0013","article-title":"Prescription of opioids for acute pain in opioid naive patients","author":"Pino","year":"2021","journal-title":"UpToDate"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0014","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1001\/jama.2016.7789","article-title":"Prescription of long-acting opioids and mortality in patients with chronic noncancer pain","volume":"315","author":"Ray","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0015","unstructured":"Centers for Disease Control and Prevention. Opioids: about CDC's opioid prescribing guideline. 2021. Available at: https:\/\/www.cdc.gov\/drugoverdose\/prescribing\/guideline.html#anchor_1561563251. Accessed July 15, 2021."},{"key":"10.1016\/j.ajogmf.2021.100475_bib0016","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/bimj.201400112","article-title":"Modeling continuous covariates with a \u201cspike\u201d at zero: bivariate approaches","volume":"58","author":"Jenkner","year":"2016","journal-title":"Biom J"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0017","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/aje\/kww122","article-title":"Modeling variables with a spike at zero: examples and practical recommendations","volume":"185","author":"Lorenz","year":"2017","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2008.05.015","article-title":"Quantile regression and restricted cubic splines are useful for exploring relationships between continuous variables","volume":"62","author":"Marrie","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0019","series-title":"Multiple imputation for nonresponse in surveys","author":"Rubin","year":"2004"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0020","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0021","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.whi.2021.03.002","article-title":"Prescription opioid dose after vaginal delivery and the risk of serious opioid-related events: a retrospective cohort study","volume":"31","author":"Wiese","year":"2021","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0022","article-title":"Prescription opioid use after vaginal delivery and subsequent persistent opioid use and misuse","volume":"3","author":"Zhu","year":"2021","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0023","series-title":"Framing opioid prescribing guidelines for acute pain: developing the evidence","year":"2020"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.03.016","article-title":"Persistent opioid use following cesarean delivery: patterns and predictors among opioid-na\u00efve women","volume":"215","author":"Bateman","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0025","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/jama.2018.6933","article-title":"Opioid overdose after surgical discharge","volume":"320","author":"Ladha","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0026","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/AOG.0000000000002093","article-title":"Patterns of opioid prescription and use after cesarean delivery","volume":"130","author":"Bateman","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0027","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/rapm-2020-102007","article-title":"Effect of a stepwise opioid-sparing analgesic protocol on in-hospital oxycodone use and discharge prescription after cesarean delivery","volume":"46","author":"Landau","year":"2021","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0028","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1055\/s-0040-1716906","article-title":"Associations among discharge opioid prescribing and inpatient postpartum opioid usage after","volume":"10","author":"Veade","year":"2020","journal-title":"AJP Rep"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0029","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1213\/ANE.0000000000004993","article-title":"Effects of state law limiting postoperative opioid prescription in patients after cesarean delivery","volume":"132","author":"Potnuru","year":"2021","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0030","first-page":"252","article-title":"ACOG Committee Opinion No. 742 summary: postpartum pain management","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0031","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/jog.13579","article-title":"Home opioid use following cesarean delivery: how many opioid tablets should obstetricians prescribe?","volume":"44","author":"Schmidt","year":"2018","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0032","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.bja.2018.04.033","article-title":"Prediction of outliers in pain, analgesia requirement, and recovery of function after childbirth: a prospective observational cohort study","volume":"121","author":"Komatsu","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0033","first-page":"36","article-title":"Opiate prescribing practices in the postpartum unit","volume":"18","author":"Nakahara","year":"2018","journal-title":"Ochsner J"},{"key":"10.1016\/j.ajogmf.2021.100475_bib0034","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2018.4234","article-title":"Association of opioid prescribing with opioid consumption after surgery in Michigan","volume":"154","author":"Howard","year":"2019","journal-title":"JAMA Surg"}],"container-title":["American Journal of Obstetrics & Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933321001701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933321001701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:48:14Z","timestamp":1762904894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933321001701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2589933321001701"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2021.100475","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The risk of serious opioid-related events associated with common opioid prescribing regimens in the postpartum period after cesarean delivery","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2021.100475","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100475"}}